Israel Englander Seres Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,810,719 shares of MCRB stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,810,719

Previous 1,021,957 77.18%

Holding current value

$1.21 Million

Previous $970,000 54.85%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.55 - $0.98 $433,819 - $772,986	788,762 Added 77.18%	1,810,719 $1.5 Million
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.48 $528,950 - $1.12 Million	-755,644 Reduced 42.51%	1,021,957 $970,000
Q2 2024 Aug 14, 2024	BUY	$0.56 - $1.19 $420,027 - $892,558	750,049 Added 72.99%	1,777,601 $1.28 Million
Q1 2024 May 15, 2024	SELL	$0.75 - $1.56 $897,392 - $1.87 Million	-1,196,523 Reduced 53.8%	1,027,552 $791,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $431,669 - $997,946	464,161 Added 26.37%	2,224,075 $3.11 Million
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $6.31 Million - $8.85 Million	1,351,434 Added 330.84%	1,759,914 $8.43 Million
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $1 Million - $1.24 Million	203,008 Added 98.8%	408,480 $2.32 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $1.05 Million - $1.86 Million	205,472 New	205,472 $1.15 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $1.36 Million - $3.85 Million	504,624 Added 85.63%	1,093,910 $3.75 Million
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $4.25 Million - $5.97 Million	-675,200 Reduced 53.4%	589,286 $4.2 Million
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $5.88 Million - $11.2 Million	976,368 Added 338.88%	1,264,486 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $439,917 - $1.82 Million	80,571 Added 38.82%	288,118 $2.01 Million
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $1.1 Million - $1.45 Million	-59,574 Reduced 22.3%	207,547 $4.95 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $876,430 - $1.44 Million	-49,628 Reduced 15.67%	267,121 $5.5 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $810,820 - $1.32 Million	34,874 Added 12.37%	316,749 $7.76 Million
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $330,544 - $2.54 Million	-88,381 Reduced 23.87%	281,875 $7.98 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $1.13 Million - $2.3 Million	370,256 New	370,256 $1.76 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $737,050 - $1.34 Million	-321,856 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.28 - $7.35 $634,555 - $2.05 Million	278,314 Added 639.19%	321,856 $1.04 Million
Q2 2019 Aug 14, 2019	SELL	$2.28 - $7.35 $564,865 - $1.82 Million	-247,748 Reduced 85.05%	43,542 $2.17 Million
Q1 2019 May 14, 2019	BUY	$4.83 - $7.21 $1.41 Million - $2.1 Million	291,290 New	291,290 $2 Million
Q4 2018 Feb 14, 2019	SELL	$4.52 - $8.88 $66,683 - $131,006	-14,753 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $1.15 Million - $1.45 Million	-157,420 Reduced 91.43%	14,753 $112,000
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $596,664 - $824,623	86,348 Added 100.61%	172,173 $1.48 Million
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $1.54 Million - $2.34 Million	-209,850 Reduced 70.97%	85,825 $630,000
Q4 2017 Feb 14, 2018	BUY	$9.15 - $12.64 $777,164 - $1.07 Million	84,936 Added 40.3%	295,675 $3 Million
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $2.7 Million - $3.55 Million	210,739	210,739 $3.38 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

41.3M

Call Options Held

2.96M

Put Options Held

228K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $83.1M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account